The correlation between WNT signaling activation and resistance to immune checkpoint blockade, such as CTLA-4 and PD(L)-1, was identified in melanoma [15,16] and hepatocellular carcinoma (HCC) [17]. This evidence concerns the gene CTLA4 and hepatocellular carcinoma.